This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Four oncology-services deals probed simultaneously by Australian competition watchdog

By Ryan Cropp ( March 22, 2024, 05:30 GMT | Insight) -- Cancer services provider Icon Group has found itself at the center of a regulatory storm, after Australia’s competition watchdog today announced four parallel reviews into various deals proposed by the company. The deals involve the acquisition of leases to oncology clinics at hospitals on the outskirts of Melbourne and Brisbane, as well as a joint venture with medical-technology provider Cyberknife Australia to establish six new radiation-oncology clinics.Cancer services provider Icon Group has found itself at the center of a regulatory storm, after Australia’s competition watchdog today announced four parallel reviews into various deals proposed by the company....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login